search
NASDAQ:AKTX
USD
1.34
- (-3.8%)
AKARI THERAPEUTICS, PLC
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
USD 1.340
- (-3.8%)
End of Day: 8 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing inhibitors of acute and chronic inflammation which includes the complement system, the bioamine system...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices